The rising prevalence of hepatitis c virus along with liver cancer is driving the global market says Fortune Business Insights in a report “Hepatitis C Testing Market Size, Share and Global Trend, By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), By Test (Antibody Test, Genotype Tests, Viral Load Test), By End-User (Hospital-based Laboratories, Stand-alone Laboratories, Others), and Geography Forecast till 2026.” The rising number of government programs for spreading awareness about hepatitis c is likely to support the growth of the global hepatitis market.
Innovation In Hepatitis Testing System Will Give Quick Results
Hepatitis C is primarily caused by the hepatitis c virus, consisting of three types of hepatitis mainly named as hepatitis A, B, and C. Hepatitis C market on the basis of technique is segmented into immunoassays, polymerase chain reaction (PCR), others. On the basis of test the market is segmented into antibody test, genotype tests, viral load test. Acquisition of companies for the development of diagnostic is expected to encourage growth of the global hepatitis c testing market. For Instance, Access Bio Inc. and Atomo Diagnostics announced the development of the rapid diagnostic test (RDT) for screening for hepatitis C virus (HCV). Furthermore, increasing cases of liver cancer and high diagnosis rates for hepatitis c in emerging nations are likely to drive the global market for hepatitis c testing. In addition, the rising number of government programs for spreading awareness concerning hepatitis C testing is also a key factor contributing to the growth of the hepatitis C market. Hepatitis C testing has been made compulsory for organ donation in various regions, this factor is also likely to fuel demand and enable the growth of the hepatitis C testing market.
Top Key Players Covered:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the global Hepatitis C Testing market. Some of the companies operating the global Hepatitis C Testing market are;
- OraSure Technologies, Inc.
- Siemens Healthcare Private Limited
- Bio-Rad Laboratories, Inc.
- Bayer AG, QIAGEN
- Thermo Fisher Scientific Inc.
- Polymerase Chain Reaction (PCR)
- Antibody Test
- Genotype Tests
- Viral Load Test
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
More Trending Topics From Fortune Business [email protected]